Topamax Related Published Studies
Well-designed clinical trials related to Topamax (Topiramate)
A comparative study of the effects of low-dose topiramate versus sodium valproate
in migraine prophylaxis. [2012]
Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP). [2011.11.03]
Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. [2011.10.19]
Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. [2011.10]
A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. [2011.10]
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial. [2011.06.01]
Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. [2011.05]
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. [2011.05]
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. [2011.04.16]
A double-blind, placebo-controlled trial of topiramate for pathological gambling. [2011.04.12]
Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. [2011.02]
Topiramate dose effects on cognition: a randomized double-blind study. [2011.01.11]
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. [2011.01]
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. [2011.01]
Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly. [2011]
Topiramate for the treatment of alcohol dependence: comparison with naltrexone. [2011]
Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized
clinical trial. [2011]
Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled
trial. [2011]
Topiramate augmentation in patients with resistant major depressive disorder: a
double-blind placebo-controlled clinical trial. [2011]
Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial. [2010.11.01]
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate. [2010.11]
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. [2010.10.01]
Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. [2010.10]
Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. [2010.07.08]
Relative bioavailability study with two oral formulations of topiramate using a validated UPLC-MS/MS method. [2010.05]
Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial. [2010.05]
Migraines with and without aura and their response to preventive therapy with topiramate. [2010.05]
A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. [2010.04]
Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. [2010.03.02]
Cognitive effects of topiramate in migraine patients aged 12 through 17 years. [2010.03]
Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial. [2010.02]
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. [2010.01]
Clinical assessment of topiramate therapy in patients with migrainous vertigo. [2010.01]
Double-blind, placebo-controlled trial of risperidone plus topiramate in children
with autistic disorder. [2010]
Efficacy, tolerability, and safety of rapid initiation of topiramate versus
phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical
trial. [2010]
Randomized trial of adjunctive topiramate therapy in infants with refractory
partial seizures. [2010]
Comparison of topiramate and risperidone for the treatment of behavioral
disturbances of patients with Alzheimer disease: a double-blind, randomized
clinical trial. [2010]
A randomised, double-blind, placebo-controlled study of topiramate in the
treatment of Tourette syndrome. [2010]
Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. [2009.12]
Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. [2009.11.01]
A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. [2009.11]
Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. [2009.10]
A Randomized, Double-Blind, Placebo-Controlled Study of Topiramate in the Treatment of Tourette Syndrome. [2009.09.01]
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. [2009.09]
A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. [2009.08]
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. [2009.08]
A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. [2009.05.29]
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. [2009.03]
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. [2009.03]
Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. [2009.03]
Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. [2009.02]
A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. [2008.12]
Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. [2008.12]
Comparing topiramate with naltrexone in the treatment of alcohol dependence. [2008.12]
A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. [2008.11]
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. [2008.09.12]
A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. [2008.07.10]
Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study. [2008.07]
Using topiramate or naltrexone for the treatment of alcohol-dependent patients. [2008.07]
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. [2008.06.09]
Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. [2008.06]
Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. [2008.06]
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. [2008.06]
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial. [2008.05.07]
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial. [2008.05.07]
Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. [2008.04.28]
Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. [2008.04]
Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials. [2008.03]
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. [2008.03]
Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. [2008.03]
Treatment of aggression with topiramate in male borderline patients, part II: 18-month follow-up. [2008.03]
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. [2008.02]
Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study. [2008]
A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. [2007.12]
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. [2007.12]
The impact of topiramate on health-related quality of life indicators in chronic migraine. [2007.11]
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. [2007.11]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Topiramate for treating alcohol dependence: a randomized controlled trial. [2007.10.10]
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. [2007.10.04]
Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation. [2007.10]
Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine. [2007.10]
Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. [2007.09]
The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. [2007.09]
A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. [2007.09]
Time course of adverse events most commonly associated with topiramate for migraine prevention. [2007.08]
Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy. [2007.07.25]
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. [2007.07]
Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial. [2007.07]
Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. [2007.07]
Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine. [2007.07]
Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison. [2007.06]
Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. [2007.06]
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. [2007.06]
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients. [2007.06]
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. [2007.05.01]
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. [2007.04.18]
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. [2007.03.30]
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. [2007.02]
Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. [2007.02]
|
